Newsletter Subject

What to Know About New Tools to Fight RSV

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Wed, Aug 23, 2023 10:52 PM

Email Preheader Text

Daily Headlines Wednesday, August 23, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIG

[MEDPAGE TODAY]( Daily Headlines Wednesday, August 23, 2023 Today's Top Stories for {NAME} [SPECIAL REPORTS]( [What to Know About New Tools to Fight RSV]( [NEUROLOGY]( [Novel Brain Implants Help Paralyzed People Speak Faster, More Accurately]( [DERMATOLOGY]( [Mohs Surgery Best for Early-Stage Merkel Cell Carcinoma?]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Evidence-Based Management of Adverse Effects of Immunotherapy in Relapsed/Refractory Multiple Myeloma]( [ONCOLOGY/HEMATOLOGY]( [Novel KRAS Inhibitor Leads to Durable Responses in Multiple Tumor Types]( [INFECTIOUS DISEASE]( [Partial Resistance to Therapeutic Mainstay for Malaria on the Rise]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [SPECIAL REPORTS]( [Experts Keeping Close Eye on BA.2.86 Variant]( CME SPOTLIGHT [Novel Mechanisms and Therapeutic Targets in Relapsed/Refractory Multiple Myeloma]( [THE BREAK ROOM]( [Spell Check-Up: Can You Spell These Medical Words?]( [PSYCHIATRY]( [Postpartum Dads; Obits Now Naming Suicide; N.J. Doubles Involuntary Hold Time]( [OPINION]( [In a Pig's Eye: Xenograft Kidneys for the Dead]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [OPHTHALMOLOGY]( [Cornea Stem Cell Transplants Helped Restore Vision After Chemical Burns]( [PODCASTS]( [MedPod Today: The Medical Misinformation Mess]( [RHEUMATOLOGY]( [Still No Easy Way to Take RA Patients Off Anti-TNF Drugs]( CME SPOTLIGHT [Treatment and Management of Patients with HER2+ Advanced/Metastatic Breast Cancer]( [ONCOLOGY/HEMATOLOGY]( [Introducing the National Comprehensive Cancer Network's New CEO]( [PSYCHIATRY]( [Less Burdensome PTSD Therapy Proves Viable]( [CARDIOLOGY]( [PRECISE Data Validate Deferral of CAD Testing for Low-Risk Patients]( CME SPOTLIGHT [Applying the Latest Clinical Evidence and Guideline Recommendations for CAR T-cell Therapy in Non-Hodgkin Lymphoma]( [ASCO READING ROOM]( [Ursula Matulonis, MD, on a Promising Combo for Recurrent, Platinum-Resistant Ovarian Cancer]( [MEDICAL JOURNEYS]( [Case Study: Incidental Finding of Enlarged Kidney Leads to an Unexpected Endometriosis-related Diagnosis]( [CARDIOLOGY]( [FDA Panel Backs ReCor's Renal Denervation System for Hypertension]( CME SPOTLIGHT [Evidence-Based Strategies for Integrating CAR T-Cell Therapy Into Non-Hodgkin Lymphoma Care]( # Weekly Survey ['I'm an Accountant. And You?']( In social situations, telling people you're a healthcare professional [can lead to some unwanted conversations](.[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-08-23&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

23/06/2024

Sent On

23/06/2024

Sent On

22/06/2024

Sent On

21/06/2024

Sent On

21/06/2024

Sent On

21/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.